M J Stassar
Overview
Explore the profile of M J Stassar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
99
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stassar M, Devitt G, BROSIUS M, Rinnab L, Prang J, Schradin T, et al.
Br J Cancer
. 2001 Nov;
85(9):1372-82.
PMID: 11720477
Renal cell carcinoma (RCC) are frequently chemo- and radiation resistant. Thus, there is a need for identifying biological features of these cells that could serve as alternative therapeutic targets. We...
2.
Stassar M, Raddrizzani L, Hammer J, Zoller M
Immunobiology
. 2001 Sep;
203(5):743-55.
PMID: 11563674
Recently, epitope prediction software for HLA-DR binding sequences has become available. In view of the importance of T helper (Th) cell activation in immunotherapy of cancer and evidences supporting immunogenicity...
3.
Schmitt W, Stassar M, Schmitt W, Little M, Cochlovius B
J Cancer Res Clin Oncol
. 2001 Mar;
127(3):203-6.
PMID: 11260867
Purpose: To design a tumor-specific immunotherapeutic strategy for treating tumors for which no specific antigens are described (such as bladder urothelial carcinoma), we attempted to activate tumor-specific T-cells by dendritic...
4.
Cochlovius B, Kipriyanov S, Stassar M, Schuhmacher J, Benner A, Moldenhauer G, et al.
Cancer Res
. 2000 Sep;
60(16):4336-41.
PMID: 10969772
To increase the valency, stability, and therapeutic potential of bispecific antibodies, we have constructed a tetravalent tandem diabody (Tandab) that is specific to both human CD3 (T-cell antigen) and CD19...
5.
Cochlovius B, Kipriyanov S, Stassar M, Christ O, Schuhmacher J, Strauss G, et al.
J Immunol
. 2000 Jul;
165(2):888-95.
PMID: 10878363
The use of anti-CD3 x antitumor bispecific Abs is an attractive and highly specific approach in cancer therapy. Recombinant Ab technology now provides powerful tools to enhance the potency of...
6.
Stassar M, Pitzer C, Zoller M
Oncol Res
. 1999 Sep;
11(2):85-90.
PMID: 10489164
Messenger RNA differential display was used to identify genes that are differentially expressed in normal kidney and kidney tumors. We isolated a clone that was uniquely expressed in the normal...
7.
Stassar M, Vegt P, Steerenberg P, van der Meijden A, Meiring H, Geertzen H, et al.
Urol Res
. 1994 Jan;
22(3):177-84.
PMID: 7992464
Because recent investigations showed that the use of isoniazid (INH) severely impaired the local immune reaction to intravesical bacillus Calmette-Guérin (BCG) in the bladder of guinea pigs, in this study...